Revenue Growth QoQ: ChromaDex Corp. (NAGE)

The quarterly revenue growth rate reflects dynamics linked to the Tru Niagen patent protection and the development of the B2B channel, where the current parameter equals -20.10. Chromadex Corp generates revenue by supplying cellular energy components to cosmetics manufacturers. Business resilience is driven by stable demand for anti-aging supplements, rendering the financial results of Chromadex Corp largely independent of macroeconomic downturns.
ChromaDex Corp. (NAGE) - metric breakdowns and financial figures

This indicator determines investment reliability via quarterly sales volume growth rates, measuring the business's ability to generate additional cash flow relative to the previous period. By analyzing quarterly revenue growth statistics, an investor assesses the expansion efficiency of Chromadex Corp (NAGE) across B2B and D2C segments, confirming the success of its strategy to dominate the NAD+ regulator market using the patented Niagen.